会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明申请
    • METHOD FOR PRODUCING A PALLADIUM-CONTAINING HYDROGENATION CATALYST
    • 生产含铂氢化催化剂的方法
    • WO2005007288A1
    • 2005-01-27
    • PCT/RU2004/000263
    • 2004-07-06
    • B01J37/03
    • B82Y30/00B01J21/18B01J23/44B01J37/031B01J37/16Y10S423/39Y10S423/40Y10S977/734Y10S977/735Y10S977/74Y10S977/742Y10S977/748
    • The invention relates to physical chemistry and can be used for adjusting the rate of autocatalytic hydrogenation reactions. The inventive method for producing a palladium-containing hydrogenation catalyst by reducing divalent palladium from the initial compound thereof and by precipitating the thus reduced palladium on a carbon material. According to said invention, the initial compound is embodied in the form of tetra aqua-palladium (II) perchlorate. The reduced palladium is precipitated on a nano-carbon material which can be embodied in the form of fullerene C60, carbon nanotubes, cathodic deposit and the mixture of C60 and C70 fullerenes at the following ratio thereof: 60 mass % fullerene C60 and 20-40 mass % fluorine C70. The invention makes it possible to develop the method for producing a palladium-containing hydrogenation catalyst which exhibits a higher catalytic activity and operates in softer conditions (at a room temperature and a normal (atmospheric) pressure).
    • 本发明涉及物理化学,可用于调节自催化氢化反应的速率。 本发明的通过从其初始化合物中还原二价钯并通过将如此还原的钯沉淀在碳材料上来制备含钯氢化催化剂的方法。 根据所述发明,初始化合物以四水合钯(II)高氯酸盐的形式实施。 还原的钯在纳米碳材料上沉淀,其可以以富勒烯C60,碳纳米管,阴极沉积物和C60和C70富勒烯的混合物的形式按以下比例实施:60质量%富勒烯C60和20-40 质量%氟C70。 本发明使得可以开发出具有较高催化活性并在较软条件(室温和正常(大气压))下操作的含钯氢化催化剂的方法。
    • 6. 发明申请
    • NANOSPEARING FOR MOLECULAR TRANSPORTATION INTO CELLS
    • 用于分子运输到细胞中的纳米粒子
    • WO2007018562A2
    • 2007-02-15
    • PCT/US2005033975
    • 2005-09-22
    • NANOLAB INC
    • CAI DONGCARNAHAN DAVID L
    • C12N15/09C12N15/87
    • C12N15/89C12M35/02C12N15/87Y10S977/746Y10S977/748
    • A nanostructured molecular delivery vehicle comprising magnetic materials and configured to receive passenger biomolecules. The application of a an appropriate magnetic field having a gradient orients and drives the vehicle into a biological target, which may comprise cells,cell masses, tissue slices, tissues, etc. Under the control of the magnetic field, these vehicles can penetrate cell membranes. Then, the biomolecules carried by the vehicle can be released into the cells to perform their functions. Using this "nanospearing" technique, unprecendented high transfection efficiency has been achieved in several difficult-to-transfect cells. These include, but are not limited to, Bal 17 cells, ex vivo B cells, primary cultured cortical neurons, etc. This method advances the state of the art, providing an improved technique for the introduction of exogenous molecules to cells, with the clinical applications including, but not being limited to, drug delivery, gene therapy, vaccination, etc.
    • 纳米结构分子递送载体,其包含磁性材料并且构造成接收乘客生物分子。 施加具有梯度的合适的磁场定向并将车辆驱动到可包括细胞,细胞块,组织切片,组织等的生物靶中。在磁场的控制下,这些载体可以穿透细胞膜 。 然后,车辆携带的生物分子可以释放到细胞中以发挥其功能。 使用这种“纳米级”技术,在几个难以转染的细胞中已经实现了非常重要的高转染效率。 这些方法包括但不限于Bal 17细胞,离体B细胞,原代培养的皮层神经元等。这种方法促进了现有技术的进步,提供了一种用于将外源性分子引入细胞的改进技术,临床 应用包括但不限于药物递送,基因治疗,疫苗接种等